Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
56.1M
-
Shares change
-
+4.49M
-
Total reported value, excl. options
-
$635M
-
Value change
-
+$37.7M
-
Put/Call ratio
-
0.75
-
Number of buys
-
67
-
Number of sells
-
-51
-
Price
-
$11.32
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q1 2024
153 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.1M shares
of 67.1M outstanding shares and own 83.59% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.14M shares), Paradigm Biocapital Advisors LP (7.9M shares), Logos Global Management LP (4.38M shares), Deep Track Capital, LP (3.23M shares), BlackRock Inc. (3.22M shares), STATE STREET CORP (3.18M shares), VANGUARD GROUP INC (2.41M shares), MPM BIOIMPACT LLC (1.95M shares), DIMENSIONAL FUND ADVISORS LP (1.94M shares), and Vivo Capital, LLC (1.87M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.